BJMO - volume 8, issue 3, july 2014
T. Pecceu MD, C. Weltens MD, PhD, P. Neven MD, PhD, S. Peeters MD, PhD, H. Wildiers MD, PhD
Breast cancer is the most common malignancy in women in the Western world. Over the last decades, the use of postoperative systemic therapies (chemotherapy, hormonal therapy, trastuzumab) and radiotherapy led to significant survival benefits for patients with early breast cancer. Although these modalities have been extensively studied and used, a major question is how these systemic therapies are optimally sequenced with radiotherapy in the adjuvant setting. This article reviews available data on how to combine systemic therapies with radiotherapy in women with early stage breast cancer, and provides recommendations that unfortunately do not reach level I evidence due to insufficient quality of available clinical data.
BELG J MED ONCOL 2014;8(3):72–80
Read moreBJMO - volume 6, issue 1, february 2012
H. Wildiers MD, PhD, C. Kenis RN, PhD
SIOG, the international organisation of geriatric oncology, organised its annual congress this year in Paris. Over 300 health care workers from all over the world participated in this meeting.
(BELG J MED ONCOL 2012;6:37)
Read moreBJMO - volume 6, issue 1, february 2012
J. De Grève MD, PhD, L. Dirix MD, P. Vuylsteke MD, H. Wildiers MD, PhD
2011 has been a rich year in progress on cancer care. Items already mentioned last year have been confirmed in full papers and are entering daily clinical practice. This article summarises the highlights in oncology of the past year.
(BELG J MED ONCOL 2012;6:38–41)
Read moreBJMO - volume 6, issue 1, february 2012
J. De Grève MD, PhD, L. Dirix MD, P. Vuylsteke MD, H. Wildiers MD, PhD
2011 has been a rich year in progress on cancer care. Items already mentioned last year have been confirmed in full papers and are entering daily clinical practice. This article summarises the highlights in oncology of the past year.
(BELG J MED ONCOL 2012;6:38–41)
Read more
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
